1992
DOI: 10.1177/096120339200100307
|View full text |Cite
|
Sign up to set email alerts
|

Antigen-Binding Diversity of Human Hybridoma Autoantibodies Derived from Splenocytes of Patients with SLE

Abstract: The antigen-binding specificity of human hybridoma-derived monoclonal autoantibodies (mAb) was analysed with mAbs derived from the spleens of two patients with active systemic lupus erythematosus (SLE). From one patient 72 mAbs (RSP clones) and from the other 173 mAbs (RT clones) were obtained. The binding specificity of these mAbs was analysed by solid- and fluid-phase ELISA against the autoantigens ssDNA, dsDNA, cardiolipin, SmRNP, histones, Sm-D and SS-B (La) synthetic peptides, and foreign antigens includi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
12
0

Year Published

1993
1993
2009
2009

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(13 citation statements)
references
References 24 publications
1
12
0
Order By: Relevance
“…This result was in good agreement with other data showing that autoantibodies to ubiquitin are detectable by ELISA in about 80% of lupus patients and in 0-13% only of patients with SS, RA, juvenile chronic arthritis, SSc, sarcoidosis, and normal individuals [31]. Human monoclonal antibodies reacting either with ubiquitin or with the UH2A branched peptide were also successfully generated by fusion of a human cell line with splenocytes from a young girl with active SLE who required splenectomy for severe thrombocytopenia [32]. Furthermore, using rabbit antibodies to UH2A peptide, it was possible to visualize UH2A deposits in renal biopsies from lupus patients [33].…”
Section: Histone Ubiquitination and Autoimmunitysupporting
confidence: 90%
“…This result was in good agreement with other data showing that autoantibodies to ubiquitin are detectable by ELISA in about 80% of lupus patients and in 0-13% only of patients with SS, RA, juvenile chronic arthritis, SSc, sarcoidosis, and normal individuals [31]. Human monoclonal antibodies reacting either with ubiquitin or with the UH2A branched peptide were also successfully generated by fusion of a human cell line with splenocytes from a young girl with active SLE who required splenectomy for severe thrombocytopenia [32]. Furthermore, using rabbit antibodies to UH2A peptide, it was possible to visualize UH2A deposits in renal biopsies from lupus patients [33].…”
Section: Histone Ubiquitination and Autoimmunitysupporting
confidence: 90%
“…Monoclonal aCL from MRL-lpr mice, from normal human subjects, and from SLE patients can be classified into 3 categories in terms of DNA binding: those that bind exclusively to ssDNA, those that bind to both dsDNA and ssDNA, and those without DNA binding (26,33,34,36,39). In this study, monoclonal aCL from patients with the APS did not react with either dsDNA or ssDNA, independent of p2-GPI.…”
Section: Discussionmentioning
confidence: 99%
“…We reported a detailed analysis of the antigen binding profile of 19 human MAbs from a selection of 245 clones derived from the spleens of two patients with SLE. 10 We have now extended this study and analysed the binding specificity of these aPL antibodies to a variety of negatively charged and neutral phospholipids, and examined their functional effects in anticoagulation assays.…”
Section: Introductionmentioning
confidence: 99%